Press News

Press News

Press News | 27.02.2025

Print:
Title Media Publ. Date
A national strategic support for rare patients is necessary Daily PharmaNews 26/02/2025
Clinical Trials: An investment with multiple and substantial benefits Anaptyxi ΕΒΕΑ 01/02/2025
Appointment in medicine canceled after reactions Kathimerini 27/02/2025
Employers propose a gross minimum wage of up to €871.50 Naftemporiki 27/02/2025

 

See here the publicity

 

Web Monitoring Report for the period 26/02- 27/02

Title Media Publ. Date
National Program “PROLAMVANO” for cardiovascular diseases: 5.2 million beneficiaries – First SMS sent today cnn.gr 26/02/2025
Doses of vaccines are lost where a pharmacist is not involved farmakeutikoskosmos.gr 27/02/2025
SFEE: New study on diabetes and the healthcare system healthpharma.gr 27/02/2025
Problem with personal data in the transfer of digital medical records iatronet.gr 27/02/2025
Catastrophic health expenses for 1 in 10 households in Greece – The country ranks first in depression insider.gr 27/02/2025
Adonis Georgiadis visited the pharmaceutical companies ABBVIE and SANOFI news4health.gr 26/02/2025
The rare liver disease diagnosed at 55 – Treatment in chronic shortage ygeiamou.gr 27/02/2025
The importance of prevention and proactive screening for diseases affecting 500,000 people in Greece ygeiamou.gr 27/02/2025
Rareland: A Film About Rare Diseases – The Screenwriter Speaks to ygeiamou ygeiamou.gr 26/02/2025
The challenges in diagnosing and treating rare diseases – 40% of patients are initially misdiagnosed ygeiamou.gr 26/02/2025

RELATED NEWS

Skip to content